From alternative methods to a new toxicology

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 77, Issue 3, 2011, Pages 338-349

  Hartung, Thomas ^a,b  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b UNIVERSITY OF KONSTANZ   (Germany)

Author keywords

Alternative methods; Animal testing; Evidence based medicine; Omics technologies; Toxicology; Validation

Indexed keywords

ANIMAL TESTING ALTERNATIVE; ANIMAL WELFARE; BIOINFORMATICS; CLINICAL PRACTICE; ECONOMICS; EVIDENCE BASED MEDICINE; HEALTH CARE PERSONNEL; HUMAN; IN VIVO STUDY; LAW; NONHUMAN; PREDICTIVE VALUE; QUALITY CONTROL; QUANTITATIVE ANALYSIS; REVIEW; RISK ASSESSMENT; TOXICITY TESTING; VALIDATION STUDY;

ANIMAL USE ALTERNATIVES; ANIMAL WELFARE; ANIMALS; COSMETICS; EVIDENCE-BASED MEDICINE; GOVERNMENT REGULATION; HUMANS; RISK ASSESSMENT; TOXICITY TESTS; TOXICOLOGY;

EID: 79952313498     PISSN: 09396411     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejpb.2010.12.027     Document Type: Review

References (84)

1. W.S. Russel WMS, R.L. Burch, The principles of humane experimental technique, Methuen, London, 1959. 〈http://altweb.jhsph.edu/pubs/books/ humane-exp/het-toc〉.
2. T. Hartung, Lessons learned from alternative methods and their validation for a new toxicology in the 21st century, J. Toxicol. Environ. Health B 13 (2010) 277-290.
3. National Research Council, Committee on Toxicity Testing and Assessment of Environmental Agents, Toxicity Testing in the 21st Century: A Vision and a Strategy, The National Academies Press, 2007. 〈http://www.nap.edu/catalog. php?record-id=11970〉.
4. B.J. Blaauboer, M.E. Andersen, The need for a new toxicity testing and risk analysis paradigm to implement REACH or any other large scale testing initiative, Arch. Toxicol. 81 (2007) 385-387.
5. S. Gibb, A review of the National Research Council report toxicity testing in the 21st century: a vision and a strategy, Reprod. Toxicol. 25 (2008) 136-138.
6. M.E. Andersen, D. Krewski, Toxicity testing in the 21st century: bringing the vision to life, Toxicol. Sci. 107 (2009) 324-330.
7. R.J. Kavlock, The future of toxicity testing - the NRC vision and the EPA's ToxCast program national center for computational toxicology, Neurotoxicol. Teratol. 31 (2009) 237.
8. R.J. Kavlock, C.P. Austin, R.R. Tice, Commentary - toxicity testing in the 21st century: implications for human health risk assessment, Risk Analysis 29 (2009) 485-487.
9. F.S. Collins, G.M. Gray, J.R. Bucher, Toxicology: transforming environmental health protection, Science 319 (2008) 906-907. (Pubitemid 351263750)
10. EPA, 2009. 〈http://www.epa.gov/osa/spc/toxicitytesting/〉.
11. M. Firestone, R. Kavlock, H. Zenick, M. Kramer, The U.S. EPA Working Group on the future of toxicity testing, The U.S. Environmental Protection Agency strategic plan for evaluating the toxicity of chemicals, J. Tox. Environ. Health B 13 (2010) 139-162.
12. T. Hartung, Towards a new toxicology - evolution or revolution?, ATLA - Altern Lab. Anim. 36 (2008) 635-639.
13. European Commission, Fifth Report from the Commission to the Council and the European Parliament on the Statistics on the number of animals used for experimental and other scientific purposes in the member states of the European Union, 2007. COM/2007/675 final. 〈http://ec.europa.eu/environment/ chemicals/lab-animals/reports-en.htm〉.
14. A.A. Bottini, T. Hartung, Food for thought. . . on economics of animal testing, ALTEX 26 (2009) 3-16.
15. M. Leist, S. Kadereit, S. Schildknecht, Food for thought . . . on the real success of 3R approaches, ALTEX 25 (2008) 17-24.
16. T. Hartung, M. Leist, Food for thought . . . on the evolution of toxicology and phasing out of animal testing, ALTEX 25 (2008) 91-96.
17. M. Leist, T. Hartung, P. Nicotera, The dawning of a new age of toxicology, ALTEX 25 (2008) 103-114.
18. T. Hartung, Toxicology for the twenty-first century, Nature 460 (2009) 208-212.
19. C. Rovida, T. Hartung, Re-evaluation of animal numbers and costs for in vivo tests to accomplish REACH legislation requirements for chemicals, ALTEX 26 (2009) 187-208.
20. T. Hartung, C. Rovida, Chemical regulators have overreached, Nature 460 (2009) 1080-1081.
21. T.S. Kuhn, The Structure of Scientific Revolutions, second ed., University of Chicago Press, Chicago, 1970.
22. P. Skarabnek, J. McCormick, Follies and Fallacies in Medicine, third ed., Tarragon Press, Whithorn, 1998.
23. EUROHORC (2009). European Directive 86/609 on the protection of animals used in scientific procedures: summary of the opinions of the members of EUROHORCs on the main areas of concern on the revised draft of the Directive. 6 April 2009. 〈http://www.eurohorcs.org/SiteCollectionDocuments/EU-animals- Directive-revision-0904.pdf〉.
24. L. Festinger, A Theory of Cognitive Dissonance, Stanford University Press, Stanford, CA, 1957.
25. T. Hartung, Comparative analysis of the revised Directive 2010/63/EU for the protection of laboratory animals with its predecessor 86/609/EEC - a t4 report, ALTEX 27 (2010) 285-303.
26. T. Devolder, K. Reid, V. Rogiers, S. Webb, D. Wilkins, A review of national public funding programmes in European countries, ALTEX 25 (2008) 233-242.
27. T. Hartung, Food for thought . . . on alternative methods for cosmetics safety testing, ALTEX 25 (2008) 147-162.
28. T. Hartung, Food for thought. . . on alternative methods for chemical safety testing, ALTEX 27 (2010) 3-14.
29. T. Hartung, C. Rovida, That which must not, cannot be. . . a reply to the EChA and EDF responses to the REACH analysis of animal use and costs, ALTEX 26 (2009) 301-305.
30. ECHA (European Chemical Agency), New study inaccurate on the number of test animals for REACH, 2009 Press release posted Helsinki, 28 August 2009. 〈http://echa.europa.eu/doc/press/pr-09-11-animal-testing-20090828. pdf〉.
31. S. Bremer, C. Pellizzer, S. Hoffmann, T. Seidle, T. Hartung, The development of new concepts for assessing reproductive toxicity applicable to large scale toxicological programs, Curr. Pharm. Des. 13 (2007) 3047-3058. (Pubitemid 350130970)
32. H. Greim, M. Arand, H. Autrup, H.M. Bolt, J. Bridges, E. Dybing, R. Glomot, V. Foa, R. Schulte-Hermann, Toxicological comments to the discussion about REACH, Arch. Toxicol. 80 (2006) 121-124.
33. M. Fleischer, Testing costs and testing capacity according to the REACH requirements - results of a survey of independent and corporate GLP laboratories in the EU and Switzerland, J. Busin. Chem. 4 (2007) 96-114.
34. A.A. Bottini, T. Hartung, The economics of animal testing, ALTEX 27 (2007) 67-77.
35. J.-Y. Choi, G. Ramachandrran, M. Kandlikar, The impact of toxicity testing costs on nanomaterial regulation, Environ. Sci. Technol. 43 (2009) 3030-3034.
36. T. Hartung, Per aspirin ad astra..., ATLA - Altern. Lab. Anim. 37 (Suppl. 2) (2009) 45-47.
37. J.A. DiMasi, H.G. Grabowski, The cost of biopharmaceutical R&D: is biotech different?, Manag Decis. Econ. 28 (2007) 469-479.
38. I. Kola, J. Landis, Can the pharmaceutical industry reduce attrition rates?, Nat Rev. Drug Discov. 3 (2004) 711-715.
39. B.N. Ames, L. Swirsky Gold, Paracelsus to parascience: the environmental cancer distraction, Mut. Res. 447 (2000) 3-13.
40. D.A. Basketter, M. York, J.P. McFadden, M.K. Robinson, Determination of skin irritation potential in the human 4-h patch test, Contact Dermat. 51 (2004) 1-4. (Pubitemid 39127945)
41. T. Hartung, L. Bruner, R. Curren, C. Eskes, A.M. Goldberg, P. McNamee, L. Scott, V. Zuang, First alternative method validated by a retrospective weight-of-evidence approach to replace the Draize eye test for the identification of non-irritant substances for a defined applicability domain, ALTEX 27 (2010) 43-51.
42. G.E.P. Box, Robustness in the strategy of scientific model building, in: R.L. Launer, G.N. Wilkinson (Eds.), Robustness in Statistics, Academic Press, New York, 1979, pp. 201-236.
43. T. Hartung, Food for thought . . . on animal tests, ALTEX 25 (2008) 3-9.
44. T. Hartung, G. Daston, Are in vitro tests suitable for regulatory use? Tox. Sci. 111 (2009) 233-237.
45. M.C.M. Rietjens, G.M. Alink, Future of toxicology - low-dose toxicology and risk-benefit analysis, Chem. Res. Toxicol. 19 (2006) 977-981. (Pubitemid 44384827)
46. I.F.H. Purchase, Fraud, errors and gamesmanship in experimental toxicology, Toxicology 202 (2004) 1-20.
47. B. Wandall, S.O. Hansson, C. Ruden, Bias in toxicology, Arch. Toxicol. 81 (2007) 605-617.
48. T. Hartung, Food for thought . . . on cell culture, ALTEX 24 (2007) 143-147.
49. S. Coecke, M. Balls, G. Bowe, J. Davis, G. Gstraunthaler, T. Hartung, R. Hay, O.-W. Merten, A. Price, L. Schechtman, G. Stacey, W. Stokes, Guidance on good cell culture practice, ATLA - Altern. Lab. Anim. 33 (2005) 261-287.
50. T. Hartung, S. Hoffmann, Food for thought on. . .. in silico methods in toxicology, ALTEX 26 (2009) 155-166.
51. S.R. Johnson, The trouble with QSAR (or how I learned to stop worrying and embrace fallacy, J. Chem. Inf. Model. 48 (2008) 25-26.
52. G.M. Maggiora, On outliers and activity cliffs - why QSAR often disappoints, J. Chem. Inf. Model. 46 (2006) 1535. (Pubitemid 44185680)
53. K. Dickersin, E. Manheimer, The Cochrane Collaboration: evaluation of health care and services using systematic reviews of the results of randomized controlled trials, Clin. Obest. Gynecol. 41 (1998) 315-331. (Pubitemid 28287824)
54. N.L. Wilczynski, R.B. Haynes for the Hedges Team, Developing optimal search strategies for detecting clinically sound prognostic studies in MEDLINE: an analytic survey, BMC Med. 2 (2004) 23-27.
55. C. Rudén, The use of mechanistic data and the handling of scientific uncertainty in carcinogen risk assessments: the trichloroethylene example, Regulat. Toxicol. Pharmacol. 35 (2002) 80-94. (Pubitemid 34174543)
56. S. Hoffmann, T. Hartung, Diagnosis: Toxic! - trying to apply approaches of clinical diagnostics and prevalence in toxicology considerations, Tox. Sci. 85 (2005) 422-428.
57. S. Hoffmann, T. Hartung, Towards an evidence-based toxicology, Human Exp. Toxicol. 25 (2006) 497-513.
58. E.A. Neugebauer, J.W. Holaday, Handbook of Mediators in Septic Shock, first ed., CRC-Press, Boca Raton, 1993.
59. P.S. Guzelian, M.S. Victoroff, N.C. Halmes, R.C. James, C.P. Guzelian, Evidence-based toxicology: a comprehensive framework for causation, Human Exp. Toxicol. 24 (2005) 161-201.
60. T. Hartung, Food for thought. . . on evidence-based toxicology, ALTEX 26 (2009) 75-82.
61. C. Griesinger, S. Hoffmann, A. Kinsner-Ovaskainen, S. Coecke, T. Hartung, in: Proceedings of the First International Forum Towards Evidence-Based Toxicology, Conference Centre Spazio Villa Erba, Como, Italy, 15-18 October 2007; Human Exp. Toxicol., Evidence-Based Toxicology (EBT) 28 (2009) 81-163 (special issue).
62. K. Schneider, M. Schwarz, I. Burkholder, A. Kopp-Schneider, L. Edler, A. Kinsner-Ovaskainen, T. Hartung, S. Hoffmann, "ToxRTool", a new tool to assess the reliability of toxicological data, Toxicol. Lett. 189 (2009) 138-144.
63. T. Hartung, Evidence based-toxicology - the toolbox of validation for the 21st century? ALTEX 27 (2010) 241-251.
64. M. Macfarlane, P. Jones, C. Goebel, E. Dufour, J. Rowland, D. Arakie, M. Costabel-Farkas, N.J. Hewittg, J. Hibatallah, A. Kirst, P. McNamee, F. Schellauf, J. Scheel, A tiered approach to the use of alternatives to animal testing for the safety assessment of cosmetics: skin irritation, Regul. Tox. Pharmacol. 54 (2009) 188-196.
65. J. Jaworska, S. Gabbert, T. Aldenberg, Towards optimization of chemical testing under REACH: a Bayesian network approach to Integrated Testing Strategies, Regul. Tox. Pharmacol. 57 (2010) 157-167.
66. S. Hoffmann, A. Gallegos Saliner, G. Patlewicz, C. Eskes, V. Zuang, A.P. Worth, A feasibility study developing an integrated testing strategy assessing skin irritation potential of chemicals, Tox. Lett. 180 (2008) 9-20.
67. L.L. Smith, Key challenges for toxicologists in the 21st century, Trends Pharmacol. Sci. 22 (2001) 281-285.
68. T. Hartung, A toxicology for the 21st century: mapping the road ahead, Tox. Sci. 109 (2009) 18-23.
69. K. Boekelheide, S.N. Campion, Toxicity in the 21st century: using the new toxicity testing paradigm to create a taxonomy of adverse effects, Tox. Sci. 114 (2010) 20-24.
70. R. Corvi, H.-J. Ahr, S. Albertini, D.H. Blakey, L. Clerici, S. Coecke, G.R. Douglas, L. Gribaldo, J.P. Groten, B. Haase, K. Hamernik, T. Hartung, T. Inoue, I. Indans, D. Maurici, G. Orphanides, D. Rembges, S.-A. Sansone, J.R. Snape, E. Toda, W. Tong, J.H. Van Delft, B. Weis, L.M. Schechtman, Validation of toxicogenomics-based test systems: ECVAM-ICCVAM/NICEATM considerations for regulatory use, Environ. Health Persp. 114 (2006) 420-429.
71. T. Hartung, S. Bremer, S. Casati, S. Coecke, R. Corvi, S. Fortaner, L. Gribaldo, M. Halder, S. Hoffmann, A. Janusch-Roi, P. Prieto, E. Sabbioni, L. Scott, A. Worth, V. Zuang, A modular approach to the ECVAM principles on test validity, ATLA - Altern. Lab. Anim. 32 (2004) 467-472. (Pubitemid 40128842)
72. T. Hartung, Food for thought . . . on validation, ALTEX 24 (2007) 67-72.
73. S. Hoffmann, L. Edler, I. Gardner, L. Gribaldo, T. Hartung, C. Klein, M. Liebsch, S. Sauerland, L. Schechtman, A. Stammati, E. Nikolaidis, Points of reference in validation - the report and recommendations of ECVAM workshop, ATLA - Altern. Lab. Anim. 36 (2008) 343-352.
74. H.-J. Ahr, N. Alepee, S. Breier, C. Brekelmans, I. Cotgreave, L. Gribaldo, G. Dal Negro, O. De Silva, T. Hartung, A. Lacerda, B. Leblanc, C. Lecerf, J.P. Linge, S. Luhimies, I. Manou, G. Maxwell, K.K. Müller, W. Pape, K. Redhead, K.R. Schröder, D. Sladowski, K. van der Jagt, P. Vanparys, Barriers to validation. A report by European Partnership for Alternative Approaches to animal testing (EPAA) working group 5, ATLA 36 (2008) 459-464.
75. M. Vinken, T. Doktorova, H. Ellinger-Ziegelbauer, H.J. Ahr, E. Lock, P. Carmichael, E. Roggen, J. van Delft, J. Kleinjans, J. Castell, R. Bort, T. Donato, M. Ryan, R. Corvi, H. Keun, T. Ebbels, T. Athersuch, S.A. Sansone, P. Rocca-Serra, R. Stierum, P. Jennings, W. Pfaller, H. Gmuender, T. Vanhaecke, V. Rogiers, The carcinoGENOMICS project: critical selection of model compounds for the development of omics-based in vitro carcinogenicity screening assays, Mutat. Res. 659 (2008) 202-210.
76. S. Coecke, A.M. Goldberg, S. Allen, L. Buzanska, G. Calamandrei, K. Crofton, L. Hareng, T. Hartung, H. Knaut, P. Honegger, M. Jacobs, P. Lein, A. Li, W. Mundy, D. Owen, S. Schneider, E. Silbergeld, T. Reum, T. Trnovec, F. Monnet-Tschudi, A. Bal-Price, Incorporating in vitro alternative methods for developmental neurotoxicity into international hazard and risk assessment strategies, Environ. Health Persp. 115 (2007) 924-931.
77. T. Hartung, Food for thought. . . on alternative methods for nanoparticle safety testing, ALTEX 27 (2010) 87-95.
78. A.A. Bottini, P. Amcoff, T. Hartung, Food for thought. . . on globalization of alternative methods, ALTEX 24 (2007) 255-261.
79. M.-J.W.A. Schiffelers, B.J. Blaauboer, J. Martje Fentener van Vlissingen, J. Kuil, R. Remie, J.W.G.M. Thuring, M.A. Vaal, C.F.M. Hendriksen, Factors stimulating or obstructing the implementation of the 3Rs in the regulatory process, ALTEX 24 (2007) 273-278.
80. A.A. Bottini, N. Alepee, O. De Silva, T. Hartung, C. Hendriksen, J. Kuil, P. Pazos, B. Philips, C. Rhein, M.-J. Schiffelers, W. Stokes, A. Theobald, J.-M. Vidal, H. Van de Sandt, B. Blaauboer, Optimization of the post-validation process. The report and recommendations of ECVAM workshop 67, Altern. Lab. Anim. 36 (2008) 353-366.
81. C. Eskes, V. De Moura Sa-Rocha, J. Nunes, O. Presgrave, D. de Carvalho, P. Masson, E. Rivera, S. Coecke, J. Kreysa, T. Hartung, Proposal for a Brazilian centre on alternative test methods, ALTEX 26 (2009) 265-268.
82. O. Presgrave, C. Eskes, R. Presgrave, E. Alves, J.C. Freitas, C. Caldeira, I. Gimines, R. Silva, S. Nogueira, J. Nunes, E. Rivera, V. Sá-Rocha, S. Coecke, T. Hartung, Proposal to establish a Brazilian Center for Validation of Alternative Methods (BraCVAM), ALTEX 27 (2010) 159-161 (special issue).
83. T. Hartung, H. Koeter, Food for thought . . . on alternative methods for food safety testing, ALTEX 25 (2008) 259-264.
84. T. Seidle, M.L. Stephens, Bringing toxicology into the 21st century: a global call to action, Toxicol. In Vitro 23 (2009) 1576-1579.